Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,966
Total Claims
$802K
Drug Cost
652
Beneficiaries
$1,230
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-90%
Opioid rate vs peers
0.3% vs 2.6% avg
+15%
Cost per patient vs peers
$1,230 vs $1,068 avg
+16%
Brand preference vs peers
10.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
29
Opioid Claims
$207
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,137 claims · $618K
Generic: 9,765 claims · $181K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 139 | $101K |
| Linaclotide | 82 | $70K |
| Semaglutide | 56 | $61K |
| Dulaglutide | 35 | $54K |
| Apixaban | 39 | $33K |
| Sitagliptin Phosphate | 22 | $23K |
| Insulin Degludec | 15 | $20K |
| Exenatide Microspheres | 11 | $19K |
| Rivaroxaban | 28 | $18K |
| Insulin Nph Hum/Reg Insulin Hm | 24 | $14K |
| Empagliflozin | 13 | $12K |
| Fluticasone/Umeclidin/Vilanter | 15 | $10K |
| Budesonide/Formoterol Fumarate | 12 | $8,862 |
| Insulin Nph Hum/Reg Insulin Hm | 11 | $8,150 |
| Pantoprazole Sodium | 477 | $8,086 |
Prescribing Profile
Patient Profile
75
Avg Age
56%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About